Meta-Analysis Reviews BPC-157 Preclinical Evidence for Tendon Healing

A systematic review and meta-analysis evaluating the preclinical evidence for BPC-157 in tendon repair models has been published in a peer-reviewed biomechanics journal. The analysis represents one of the most comprehensive assessments to date of the available animal evidence for this widely discussed research compound.

The review identified 14 preclinical studies meeting inclusion criteria, spanning rat, mouse, and rabbit models of tendon injury including Achilles tendon transection, rotator cuff tear, and patellar tendon defect models. Study quality was assessed using the SYRCLE risk of bias tool, and effect sizes were pooled using random-effects meta-analysis.

The pooled analysis found that BPC-157 treatment was associated with statistically significant improvements in tendon biomechanical properties compared to control groups. Specifically, treated tendons showed higher maximum load to failure, greater stiffness, and improved histological scores for collagen organisation and cellular activity. The effect sizes were moderate to large across most outcome measures.

However, the authors highlight several critical limitations. All included studies were conducted in animal models — there are no published controlled human clinical trials of BPC-157 for any indication. The majority of studies originated from a single research group in Croatia, raising concerns about independent replication. Risk of bias was assessed as unclear or high in most studies due to incomplete reporting of randomisation methods, blinding, and allocation concealment.

The authors conclude that while the preclinical signal for BPC-157 in tendon healing is consistent and biologically plausible, the evidence base does not support clinical recommendations. They call for independently conducted, adequately powered animal studies with pre-registered protocols as a necessary step before any human clinical trials would be justified.